The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.06
Bid: 14.90
Ask: 15.02
Change: -0.12 (-0.79%)
Spread: 0.12 (0.805%)
Open: 15.00
High: 15.06
Low: 14.70
Prev. Close: 15.18
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Demergers Effective and Trading Expected to Begin

6 Apr 2010 07:00

RNS Number : 7181J
EnQuest PLC
06 April 2010
 



**NOT FOR PUBLICATION, DISTRIBUTION OR RELEASEIN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA**

 

 

 

EnQuest PLC

 

Demergers effective and trading expected to commencein shares of EnQuest PLC

 

All of the conditions to the Petrofac Demergerand the Lundin Demerger have been satisfied and the Demergers have become effective.

 

Trading in EnQuest PLC Ordinary Shares under theticker "ENQ.L" is expected to commence on the London Stock Exchange at 8.00 amtoday.

 

CREST accounts of shareholders in Petrofac willbe credited with EnQuest PLC Ordinary Shares at 8.00 am today. In the case of Petrofacshareholders who hold their Petrofac ordinary shares in certificated form, sharecertificates in respect of EnQuest PLC Ordinary Shares will be dispatched to suchshareholders by 19 April 2010.

 

Conditional dealings in EnQuest PLC Ordinary Sharesare expected to commence on NASDAQ OMX Stockholm at 9.00 am CET today under the ticker"ENQ". Unconditional dealings in the Ordinary Shares on NASDAQ OMX Stockholm areexpected to commence on 9 April 2010, the date of Stockholm Admission.

 

Capitalised terms in this announcement are as definedin the Prospectus published by EnQuest PLC on 18 March 2010.

 

- Ends-

 

For further information please contact:

 

J. P. MorganCazenove Tel: +44 (0)20 7588 2828

Bob McGuire

Steve Baldwin

 

Finsbury Tel: +44 (0)20 7251 3801

Andrew Mitchell

Conor McClafferty

Dorothy Burwell

 

 

 

 

 

 

 

Disclaimer

 

 

The information contained in this announcementis for background purposes only and does not purport to be full or complete. No reliancemay be placed for any purpose on the information contained in this announcement orits accuracy or completeness.

 

This announcement is not for publication or distribution,directly or indirectly, in or into the United States. The distribution of this announcementin certain jurisdictions may be restricted by law. Persons into whose possessionthis announcement comes should inform themselves about and observe any restrictionson the distribution of this announcement. Any failure to comply with these restrictionsmay constitute a violation of the securities laws of any such jurisdictions. Personsreceiving this announcement should not distribute or send it into any jurisdictionwhere to do so would or might contravene local securities laws or regulations.

 

This announcement does not constitute or form partof an offer to sell or issue or the solicitation of an offer to subscribe for orbuy, any Ordinary Shares to any person in any jurisdiction to whom or in which suchoffer or solicitation is unlawful and, in particular, is not for distribution orpublication in or into the United States, Canada, Australia, the Republic of SouthAfrica or Japan.

 

The Ordinary Shares have not been and will notbe registered under the US Securities Act of 1933, as amended (the "Securities Act")with any securities regulatory authority or under any securities laws of any stateor other jurisdiction of the United States and may not be taken up, offered, sold,resold, transferred, delivered or distributed, directly or indirectly, within, intoor from the United States except pursuant to an applicable exemption from, or ina transaction not subject to, the registration requirements of the Securities Actand in compliance with any applicable securities laws of any state or other jurisdictionof the United States. There will be no public offer of securities in the UnitedStates.

 

The Ordinary Shares have not been and will notbe registered under the applicable securities laws of Canada, Australia, the Republicof South Africa or Japan and subject to certain exceptions, the Ordinary Shares maynot be offered or sold in Canada, Australia, the Republic of South Africa or Japanor to, or for the account or benefit of, any resident of Canada, Australia, the Republicof South Africa or Japan. There will be no public offer of securities in Canada,Australia, the Republic of South Africa or Japan.

 

J.P. Morgan Securities Ltd. (which conducts itsUK investment banking activities as J.P. Morgan Cazenove), which is authorised andregulated in the United Kingdom by the FSA, is advising the Company and no one else(whether or not a recipient of this announcement) in connection with London Admission.J.P. Morgan Securities Ltd. will not regard any other person (whether or not a recipientof this announcement) as its client in relation to London Admission and will notbe responsible to anyone other than the Company for providing the protections affordedto its clients or for providing advice in relation to London Admission or any othertransaction, arrangement or matter referred to in this announcement.

 

 

None of J.P. Morgan Cazenove, Nordea Markets, RoyalBank of Canada Europe Limited and Oriel Securities Limited or any of their respectivedirectors, officers, employees, advisers or agents accepts any responsibility orliability whatsoever for/or makes any representation or warranty, express or implied,as to the truth, accuracy or completeness of the information in this announcement(or whether any information has been omitted from the announcement) or any otherinformation relating to the Company, its subsidiaries or associated companies, whetherwritten, oral or in a visual or electronic form, and howsoever transmitted or madeavailable or for any loss howsoever arising from any use of announcement or its contentsor otherwise arising in connection therewith.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIFMATMBJMMRM
Date   Source Headline
18th May 20232:30 pmRNSEnQuest awarded offer of carbon storage licences
9th May 20237:00 amRNSEnQuest Malaysia Update
28th Apr 20232:00 pmRNSNotice of AGM
25th Apr 20239:00 amRNSAnnual Financial Report
13th Apr 20234:54 pmRNSDirectorate Change
5th Apr 20237:00 amRNSResults for the year ended 31 December 2022
17th Mar 20237:00 amRNS2022 Preliminary Results - revised date
15th Mar 202311:00 amRNSHolding(s) in Company
17th Feb 20237:00 amRNSTrading Statement
20th Dec 20221:35 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update
26th Oct 20227:00 amRNSSuccessful refinancing of capital structure
13th Oct 20227:00 amRNSPricing of new bond issue
16th Sep 20223:30 pmRNSDirector/PDMR
16th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSHalf-year Report
30th Aug 20229:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSOperations Update
1st Aug 202212:33 pmRNSDirector/PDMR Shareholding
25th Jul 202210:28 amRNSDirector/PDMR Shareholding
22nd Jul 20222:46 pmRNSDirector/PDMR Shareholding
20th Jul 20222:04 pmRNSDirector/PDMR Shareholding
18th Jul 20224:11 pmRNSDirector/PDMR Shareholding
14th Jul 20224:46 pmRNSDirector/PDMR Shareholding
20th Jun 202210:33 amRNSDirector/PDMR Shareholding
17th Jun 20223:22 pmRNSAGM Statement
17th Jun 20227:00 amRNSBoard Change
15th Jun 202212:17 pmRNSDirector/PDMR Shareholding
14th Jun 20228:44 amRNSDirector/PDMR Shareholding
1st Jun 20224:57 pmRNSHolding(s) in Company
24th May 20224:42 pmRNSNotice of AGM
23rd May 20227:00 amRNSOperations update
29th Apr 20223:00 pmRNSReport on Payments to Govts
25th Apr 20223:38 pmRNSDirector/PDMR Shareholding
25th Apr 20223:00 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSIssue of Debt
14th Apr 20223:00 pmRNSHolding(s) in Company
11th Apr 20224:45 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSProspectus publication and launch of retail notes
30th Mar 20227:00 amRNSLaunch of exchange offer
24th Mar 20227:05 amRNSAnnual Financial Report
24th Mar 20227:01 amRNSResults for the year ended 31 December 2021
24th Mar 20227:00 amRNSDirectorate Change
15th Mar 20223:00 pmRNSHolding(s) in Company
11th Mar 20223:00 pmRNSHolding(s) in Company
10th Mar 20223:00 pmRNSHolding(s) in Company
2nd Mar 20223:00 pmRNSHolding(s) in Company
28th Feb 20223:00 pmRNSHolding(s) in Company
25th Feb 20223:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.